AVXL
Price
$1.36
Change
-$0.00 (-0.00%)
Updated
Oct 22 closing price
Capitalization
126.07M
33 days until earnings call
Intraday BUY SELL Signals
TENX
Price
$1.76
Change
+$0.13 (+7.98%)
Updated
Oct 22 closing price
Capitalization
65.87M
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVXL vs TENX

AVXL vs TENX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AVXL vs. TENX commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and TENX is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AVXL with price predictions
Oct 22, 2026

AVXL sees its Stochastic Oscillator climbs out of oversold territory

On October 21, 2026, the Stochastic Oscillator for AVXL moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 59 instances where the indicator left the oversold zone. In 52 of the 59 cases the stock moved higher in the following days. This puts the odds of a move higher at over 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Moving Average Convergence Divergence (MACD) for AVXL just turned positive on October 21, 2026. Looking at past instances where AVXL's MACD turned positive, the stock continued to rise in 33 of 42 cases over the following month. The odds of a continued upward trend are 79%.

AVXL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVXL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for AVXL entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.121) is normal, around the industry mean (2.973). P/E Ratio (-9.714) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. AVXL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVXL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for TENX with price predictions
Oct 22, 2026

TENX in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 13, 2026

TENX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 36 of 41 cases where TENX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TENX's RSI Indicator exited the oversold zone, 31 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 68 cases where TENX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

Following a +19.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where TENX advanced for three days, in 191 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TENX as a result. In 72 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TENX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

The Aroon Indicator for TENX entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.580) is normal, around the industry mean (2.973). P/E Ratio (-1.189) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. TENX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TENX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
AVXL vs TENX: Fundamental Ratings
AVXL
TENX
OUTLOOK RATING
1..100
393
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
39
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
9494
P/E GROWTH RATING
1..100
1198
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVXL's Valuation (16) in the Biotechnology industry is in the same range as TENX (39) in the Medical Specialties industry. This means that AVXL’s stock grew similarly to TENX’s over the last 12 months.

AVXL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as TENX (100) in the Medical Specialties industry. This means that AVXL’s stock grew similarly to TENX’s over the last 12 months.

AVXL's SMR Rating (94) in the Biotechnology industry is in the same range as TENX (98) in the Medical Specialties industry. This means that AVXL’s stock grew similarly to TENX’s over the last 12 months.

AVXL's Price Growth Rating (94) in the Biotechnology industry is in the same range as TENX (94) in the Medical Specialties industry. This means that AVXL’s stock grew similarly to TENX’s over the last 12 months.

AVXL's P/E Growth Rating (11) in the Biotechnology industry is significantly better than the same rating for TENX (98) in the Medical Specialties industry. This means that AVXL’s stock grew significantly faster than TENX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLTENX
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (AVXL: $1.36 vs. TENX: $1.63)
Brand notoriety: AVXL and TENX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 106% vs. TENX: 42%
Market capitalization -- AVXL: $126.07M vs. TENX: $65.87M
AVXL [@Biotechnology] is valued at $126.07M. TENX’s [@Biotechnology] market capitalization is $65.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 2 FA rating(s) are green while TENX’s FA Score has 0 green FA rating(s).

  • AVXL’s FA Score: 2 green, 3 red.
  • TENX’s FA Score: 0 green, 5 red.
According to our system of comparison, AVXL is a better buy in the long-term than TENX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 4 TA indicator(s) are bullish while TENX’s TA Score has 4 bullish TA indicator(s).

  • AVXL’s TA Score: 4 bullish, 2 bearish.
  • TENX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, AVXL is a better buy in the short-term than TENX.

Price Growth

AVXL (@Biotechnology) experienced а -8.72% price change this week, while TENX (@Biotechnology) price change was +6.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

AVXL is expected to report earnings on Nov 24, 2026.

TENX is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
AVXL
Daily Signal:
Gain/Loss:
TENX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with TENX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
N/A
TENX - AVXL
47%
Loosely correlated
+7.98%
AXON - AVXL
45%
Loosely correlated
+2.98%
MAZE - AVXL
45%
Loosely correlated
-1.93%
VCYT - AVXL
41%
Loosely correlated
-0.39%
ARRY - AVXL
41%
Loosely correlated
-3.23%
More

TENX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TENX has been closely correlated with SION. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if TENX jumps, then SION could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TENX
1D Price
Change %
TENX100%
+7.98%
SION - TENX
93%
Closely correlated
-1.81%
AVXL - TENX
47%
Loosely correlated
N/A
CORT - TENX
41%
Loosely correlated
-7.55%
HRTX - TENX
40%
Loosely correlated
-12.57%
MGNX - TENX
32%
Poorly correlated
+1.11%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
YANG36.691.63
+4.65%
Direxion Daily FTSE China Bear 3X ETF (YANG)
XHB99.203.60
+3.77%
State Street SPDR S&P Homebuilders ETF (XHB)
BREE25.26-0.75
-2.88%
MFS Blended Research Emerging Markets Equity ETF (BREE)
WQTM27.35-1.25
-4.37%
WisdomTree Quantum Computing Fund (WQTM)
ONX6.37-0.66
-9.39%
Tradr 2X Long ON Daily ETF (ONX)